Discover 1,441 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,441
A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
Location: Tacoma WA, Seattle WA, Lancaster CA, Canoga Park CA,
Sponsor: Spyre Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07012395
Phase2, Recruiting
Lake Washington Vascular VenaSeal™ Post-Market Evaluation
for
Varicose Veins, Venous Reflux
Location: Issaquah WA, Bellevue WA, Kirkland WA
Sponsor: Lake Washington Vascular
Sex: All
Age: 18+
Code: NCT04146168
Recruiting
Efficacy of Intradiscal Injection of Viable Placental Tissue Extract in Subjects With One or Two Level, Symptomatic Lumbar Intervertebral Disc Degeneration
for
Degenerative Disc Disease, Pain
Location: Puyallup, Washington WA
Sponsor: Semmes-Murphey Foundation
Sex: All
Age: 0+
Code: NCT02379689
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
ELEVATE-HFpEF Clinical Study
for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Location: Tacoma WA, Vancouver, Calgary, San Francisco CA,
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Sex: All
Age: 40+
Code: NCT06678841
Recruiting
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
for
Chronic Myelogenous Leukemia - Chronic Phase
Location: Tacoma WA, Seattle WA, Salem OR, Stockton CA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07091019
Recruiting
Long COVID-19 and MAB Study
for
COVID-19
Location: Tacoma WA
Sponsor: MultiCare Health System Research Institute
Sex: All
Age: 18+
Code: NCT05508295
Recruiting
Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus
for
Esophageal Cancer, Precancerous Condition
Location: Seattle WA
Sponsor: US Department of Veterans Affairs
Sex: All
Age: 18 - 70+
Code: NCT00903136
Phase1, Phase2, Recruiting
Active & Responsive
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
for
Primary Sclerosing Cholangitis (PSC)
Location: Seattle WA, Iowa City IA, Nashville TN, Baltimore MD
Sponsor: LISCure Biosciences
Sex: All
Age: 18 - 70+
Code: NCT06699121
Phase2, Recruiting
Active & Responsive
Caloric Balance Markers Study
for
Metabolism
Location: Seattle WA
Sponsor: Institute for Systems Biology
Sex: All
Age: 18+
Code: NCT07141537
Not recruiting
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
for
Breast Cancer, Metastatic
Location: Seattle WA, Portland OR, Billings MT, Grand Junction CO,
Sponsor: ALX Oncology Inc.
Sex: All
Age: 18+
Code: NCT07007559
Phase2, Recruiting
Active & Responsive
A Study of YL201 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Tacoma WA, Kelowna, Spokane WA, Edmonton, Fair Oaks CA,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT05434234
Phase1, Phase2, Recruiting
Featured
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Seattle WA, Beverly Hills CA, Denver CO, St Louis MO,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06896916
Phase1, Recruiting
Featured
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
for
Chronic Lymphocytic Leukemia
Location: Tacoma WA, Olympia WA, Eugene OR, Clovis CA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06428019
Phase3, Recruiting
FeaturedActive & Responsive
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
for
Bipolar I Disorder, Bipolar II Disorder
Location: Bellevue WA, Everett WA, Sherman Oaks CA, Montclair CA,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06696755
Phase2, Recruiting
FeaturedActive & Responsive
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder (GAD)
Location: Bellevue WA, Everett WA, Walnut Creek CA, Las Vegas NV,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06846320
Phase2, Recruiting
FeaturedActive & Responsive
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
for
Major Depressive Disorder
Location: Bellevue WA, Everett WA, Walnut Creek CA, Las Vegas NV,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT07276997
Phase2, Recruiting
FeaturedActive & Responsive
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants